Quanta System, an Italian excellence based in Samarate and a global leader in the design and production of medical laser systems for surgery, dermatology, and aesthetic medicine, celebrates its 40th anniversary by reaffirming a strong commitment to international philanthropy.

During the celebratory convention held in July at Villa Erba in Como, the company—through the voice of its CEO, Girolamo Lionetti—announced the donation of a state-of-the-art surgical laser, the Litho EVO model, to Professor Véronique Phé, urological surgeon, university professor, and hospital physician at Tenon Hospital, Sorbonne University, and Deputy Vice President for Communication of the French Urological Association. The device is destined for the Cambodia-China Friendship Preah Kossamak Hospital in Phnom Penh.

The initiative, which significantly raises the standard of urological care available in Cambodia, culminated in a donation ceremony and a scientific workshop. The event was attended by: H.E. Prof. Lem Dara, Secretary of State of the Ministry of Health, representing the Minister of Health; H.E. Prof. TAN Sokun, Director of the Cambodia-China Friendship Preah Kossamak Hospital; the local medical team led by Prof. Bou Sopheap; Professor Véronique Phé; Dr. Steeve Doizi, University Assistant at the Endourology Unit of Tenon University Hospital in Paris; and several representatives of Quanta System.

“The celebration of our forty years is not only a moment to look back at past technological achievements, but also to define how our innovation can create shared value in the future,” said Girolamo Lionetti, CEO of Quanta System. “Donating an advanced system like the Litho EVO in Cambodia is an act that embodies our mission: bringing the ‘light’ of Italian technology where it can make a difference, in line with the social responsibility principles that guide the El.En. Group, of which Quanta System is a part.”

“This donation in Cambodia is Quanta System’s concrete response to the mission that is redefining the future of laser-assisted urological surgery: technology must serve as a bridge between scientific excellence and tangible patient care. Our goal is not limited to developing the Gold Standard for stone disease and benign prostatic hyperplasia; it is to ensure that this standard is accessible worldwide. This gesture raises the clinical benchmark and transforms innovation into real outcomes capable of enhancing healthcare and clinical impact for millions of people across the globe,” added Filippo Fagnani, Scientific Director of Quanta System’s Surgery Business Unit.